Pre-market hot trades in US stocks: Kaival Brands Innovations up 7.99% in pre-market; Tenaya Therapeutics up 7.34% in pre-market
I'm LongbridgeAI, I can summarize articles.Kaival Brands Innovations rose 7.99% in pre-market; Tenaya Therapeutics rose 7.34% in pre-market; Dongfang Culture rose 69.77% in pre-market; AMC Robotics rose 58.67% in pre-market; cbdMD rose 40.00% in pre-market
Popular Pre-Market Trades in US Stocks
Kaival Brands Innovations, up 7.99% in pre-market, with no significant news recently. Trading is active, and there is a clear flow of funds. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.
Tenaya Therapeutics is up 7.34% in pre-market. Based on recent key news:
-
On December 12, Tenaya Therapeutics announced a public offering of 50 million units at a price of $1.20 per unit, raising $60 million. This move led to a pre-market drop of over 12% in the stock price. Source: MT Newswires
-
On December 12, Tenaya Therapeutics reported positive mid-term data for its TN-401 gene therapy, showing a significant reduction in arrhythmia burden observed in patients with PKP2-related ARVC. This news drove the stock price up. Source: Reuters
-
On December 12, Chardan Capital lowered the target price for Tenaya Therapeutics from $9 to $8, reflecting market concerns about its financial performance. Source: Chardan Capital. The biotechnology sector has been volatile recently and requires attention.
Top Gainers in Pre-Market US Stocks
Oriental Culture, up 69.77% in pre-market, with no significant news recently. Trading is active, and there is a clear flow of funds. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.
AMC Robotics, up 58.67% in pre-market, with no significant news recently. Trading is active, and there is a clear flow of funds. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.
cbdMD is up 40% in pre-market. Based on recent key news:
- On December 12, the U.S. President plans to change cannabis-related regulations through an executive order. Although this move will not legalize or decriminalize cannabis, it will make it easier for related businesses to sell cannabis products and promote new research on the effects of cannabis. As a CBD distributor, cbdMD's stock price rose as a result. Following the announcement, cbdMD's stock price increased by 96.51% in pre-market trading, with a trading volume exceeding 68 million shares, far surpassing the three-month daily average trading volume of 7.54 million shares. The policy changes in the cannabis industry have significant impacts